You are here

Treating CML

Anything relating to the treatment and therapy available for CML

Post count: 
2 964
Thread count: 
432
Machine name: 
treating_cml

Recently diagnosed - options and outlook

David Fitz's picture
Submitted by David Fitz on Thu, 22/01/2026 - 3:40pm

Being diagnosed with chronic myeloid leukaemia (CML) can bring many questions - but we have great treatments available.

In these videos, Dr Ali Mahdi explains the treatment options available and what you can expect for the future. With modern therapies, most people with CML live full, active lives, and outcomes continue to improve every year.

Joanna Large, CNS, shares guidance on where to find practical and emotional support, helping you connect with resources that make day‑to‑day life a little easier.

Diagnosing, Testing, and Monitoring Chronic Myeloid Leukaemia: A guide for patients

David Fitz's picture
Submitted by David Fitz on Wed, 06/12/2017 - 2:56pm

This booklet provides an overview of the quantitative Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR) test. It includes a description of the qRT-PCR International Standardisation (IS) project within the context of the recently updated (2013) ELNet Recommendations and NCCN Treatment Guidelines for the treatment and management of Ph+CML based on molecular testing by qRT-PCR. Click on the picture of the booklet cover below to open it.


Our Publications

David Fitz's picture
Submitted by David Fitz on Wed, 06/12/2017 - 2:42pm

CML Support publish booklets and leaflets to help people understand PH+CML.

Quantitative Reverse Transcription Polymerase Chain Reaction: A primer for patients 

This booklet provides an overview of the quantitative Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR) test. It includes a description of the qRT-PCR International Standardisation (IS) project within the context of the European Leukaemia Net Recommendations and NCCN Treatment Guidelines for the treatment and management of Ph+CML based on molecular testing by qRT-PCR.

Panobinostat (LBH589) and Imatinib Mesylate in Treating Patients With Previously Treated Chronic Phase Chronic Myelogenous Leukemia

Panobinostat and imatinib mesylate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth

Panobinostat and imatinib mesylate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth

DASFREE

Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response.

Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response.

Pages